CBD in Europa: guida allo status legale e ai regolamenti

CBD in Europa: A Comprehensive Guida to Status legale and Regulations

Navigating the European legal landscape for CBD is genuinely complex. Despite the European Union's single market framework, CBD regulation remains a patchwork of EU-level directives, novel food requirements, individual member state interpretations, and evolving case law. Cos'è is legal and freely available in one European country may be restricted, grey-market, or technically prohibited in another — even when both countries are EU member states. This guide provides a clear, current overview of CBD's legal status across Europe, the regulatory frameworks that govern its sale, and the practical considerations for both consumers and businesses.

The Quadro normativo UE: THC Limits and the Novel Food Regulation

At the European Union level, industrial hemp cultivation is governed by Regulation (EU) 2021/2115, which came into effect in 2023 as part of the reformed Common Agricultural Policy. This regulation sets the maximum THC content for industrial hemp varieties at 0.3% in the standing crop, measured by dry weight. Comeever, member states retain the authority to impose stricter limits, and several — including France, Sweden, and the Czech Republic — have historically maintained or only recently raised their national limits to 0.3%. Most commercially available EU-compliant CBD products target a maximum of 0.2% THC to ensure compliance across all member states. Hemp varieties eligible for cultivation are listed in the EU Common Catalogue of Varieties of Agricultural Plant Species, and only varieties with THC levels verified below regulatory thresholds may be grown.

The Novel Food Regulation (EU) 2015/2283 represents the most significant regulatory hurdle for the CBD industry. Under this regulation, any food or food ingredient that was not consumed "to a significant degree" within the EU before May 1997 requires pre-market safety authorisation from the European Food Safety Authority (EFSA). The European Commission determined in 2019 that CBD extracts and isolate qualify as novel foods because historical consumption of hemp was limited primarily to seeds and seed oil, not concentrated cannabinoid extracts. This means that, theoretically, all CBD products marketed as food supplements within the EU require novel food authorisation. In practice, enforcement varies dramatically between member states: some (like the UK, which maintains its own version of novel food regulation post-Brexit through the Food Standards Agency) have established formal application pathways and public lists of products with validated applications, while others have taken a more permissive approach pending EFSA's full safety assessment.

As of 2026, EFSA's evaluation of CBD as a novel food ingredient remains ongoing. The agency has identified data gaps relating to liver effects, drug interactions, reproductive toxicity, and the effects of long-term daily consumption that applicants must address. This process does not mean CBD is unsafe — the World Health Organisation's 2017 critical review concluded that CBD has a good safety profile — but rather that the comprehensive toxicological dataset required for formal novel food authorisation has not yet been completed to EFSA's satisfaction. In the interim, many member states operate under a policy of enforcement discretion, permitting the sale of CBD products provided they comply with THC limits, labelling requirements, and general food safety regulations.

Paese per paese Status legale (Selected Markets)

Czech Republic: One of Europe's most CBD-friendly markets. CBD is legally sold as a food supplement and cosmetic ingredient. The country has a well-established domestic hemp industry with indoor cultivation facilities producing pharmaceutical-grade flower for extraction. THC limit: 0.3% for cultivation; finished products must remain below 0.3% THC. Heffernan's Hemp operates its cultivation and production from the Czech Republic, benefiting from a regulatory environment that supports quality-controlled CBD production.

Germany: CBD is legally available as a food supplement, cosmetic ingredient, and aromatherapy product. The German Federal Institute for Risk Assessment (BfR) has issued guidance on CBD supplement dosing, recommending a maximum daily intake of 25 mg for adults from food supplements specifically. Novel food enforcement has been inconsistent, with some regional authorities restricting certain products while permitting others. Germany is Europe's largest single CBD market by revenue and represents a significant commercial opportunity for compliant manufacturers.

France: France has historically been one of Europe's most restrictive markets for CBD. The 2020 Kanavape ruling (Case C-663/18) by the Court of Justice of the European Union was a direct result of French prosecution of CBD vape product sellers, and the ruling forced France to permit the sale of CBD products lawfully produced in other EU member states. In December 2021, the French Council of State suspended the government's ban on the sale of raw CBD flower, and the market has since opened considerably. THC limit: 0.3% for finished products, no detectable THC in the final product per some interpretations.

Spain: CBD is legally sold for topical/cosmetic use and as an "aromatic product" or "collector's item." Internal sale of CBD as a food supplement is technically restricted under Spanish food safety agency (AESAN) guidance, though enforcement is inconsistent and CBD products are widely available in retail. Spain permits cannabis social clubs for personal cultivation and consumption in certain regions (particularly Catalonia), creating a parallel cannabis culture distinct from commercial CBD regulation.

Italy: CBD is legal and widely available as a food supplement and cosmetic ingredient. Italy suspended its own decree classifying CBD as a narcotic in 2023 following a regional administrative court ruling. The Italian Ministry of Health maintains a list of permitted hemp varieties, and the THC limit for cultivation is 0.2–0.6% depending on the specific variety's certification. Light cannabis (cannabis light) — low-THC, high-CBD hemp flower sold as a "collector's item" or "technical product" — has become a significant retail category, particularly in specialist shops.

United Kingdom (post-Brexit): The UK has established a novel food application pathway through the Food Standards Agency (FSA), which maintains a public list of CBD products with validated applications that are permitted to remain on the market pending full safety assessment. The FSA recommends a maximum daily intake of 10 mg of CBD from food supplements for healthy adults, a notably conservative recommendation compared to other jurisdictions. THC limit: 0.2% for cultivation; finished products must contain no controlled substances, with THC effectively required to be non-detectable or present only at analytically insignificant levels.

Netherlands: CBD is legally available as a food supplement, provided products contain no THC whatsoever. The Dutch Food and Consumer Product Safety Authority (NVWA) has taken a strict interpretation, requiring that CBD products be entirely THC-free. Products derived from EU-approved hemp varieties with THC levels below the cultivation threshold are generally tolerated, but officially, zero THC is the standard for finished products sold as food supplements.

Sweden: Sweden represents the most restrictive interpretation of EU law regarding CBD within the bloc. The Swedish Medical Products Agency has taken the position that any CBD product intended for consumption constitutes a medicinal product by function, regardless of how it is marketed, effectively rendering CBD food supplements illegal. The Supreme Court of Sweden ruled in 2019 that CBD extracted from hemp is a narcotic under Swedish law, a position that remains in force. Consumers should exercise extreme caution when attempting to purchase or possess CBD products in Sweden.

Poland: CBD is legally available as a food supplement following clarification from the Polish Chief Sanitary Inspectorate. The market has grown significantly in recent years, with both domestic production and imported products widely available through pharmacies, health food stores, and e-commerce channels. THC limit: 0.3% for cultivation; finished products must comply with EU novel food requirements.

Guida pratica for European CBD Consumers

When purchasing CBD in Europa, the following practices will help ensure you receive a legal, safe, effective product regardless of which member state you are in. First, always verify that the product is accompanied by a batch-specific Certificate of Analysis from an independent ISO/IEC 17025-accredited laboratory confirming cannabinoid content, THC compliance below 0.2%, and absence of contaminants. Second, prioritise products manufactured in EU member states with established hemp industries — the Czech Republic, Germany, Netherlands — where supply chain integrity is easier to verify than products imported from outside the EU. Third, be aware of the specific regulations in your country and any countries you intend to transit through while carrying CBD products. Fourth, never attempt to carry CBD products across international borders where the legal status differs significantly — what is legal in the Czech Republic may not be legal in Sweden, and the consequences can be severe. At Heffernan's Hemp, we manufacture in the Czech Republic under EU-compliant conditions, publish all lab reports, and ship to countries where our products are clearly legal. When in doubt, contact us, and we will help you determine whether we can ship to your location.